A Cohort Study on Early Stages of Heart Failure

NCT06673615 · tracked via the Priya Life Science China tracker

Sponsor

Shanghai East Hospital

Phase

Observational

Started

2024-04-15

Last updated

2024-11-05

Condition(s) studied

Stages of Heart Failure

Study summary

The main goal of this observational study is to learn about the epidemiological characteristics of heart failure among elder population in Beicai community in Shanghai and construct a community-based database and biobank. The main question it aims to answer is:

What is the prevalence and prognosis of different stages of heart failure among elder population in community in Shanghai? And what are the influencing factors? What are the best screening strategies and hierarchical management strategies among different stages of heart failure patients in community? Participants are the elderly people aged 60 years or older in Beicai community in China. The follow-up will be programmed every 2 years.

Eligibility

Sex

ALL

Min age

60 Years

Max age

—

Healthy volunteers

Accepted

Inclusion Criteria: 1. Age ≥60 years 2. Cooperate in participating in research and sign informed consent forms Exclusion Criteria: 1. End stage heart failure patients 2. Refusal to participate in this study 3. Patients who are not suitable to participate in this study by Researchers\'s evaluation

Primary outcome measure(s)

All-cause mortality rate — 10 years
All-cause mortality rate of different stages of heart failure

Trial sites (1)

Facility	City	Region	Status
Shanghai East Hospital	Shanghai	Shanghai Municipality	Recruiting

More Shanghai East Hospital trials in China

Chemokine and Co-stimulatory Molecule-modified Mesenchymal Stem Cells for the Treatment of Advanced Colorectal Cancer Recruiting

Biomarkers Based EArly Diagnosis of STroke Subtype Cohort（Bio-EAST） Recruiting

Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors Recruiting

Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial Recruiting

A Clinical Trial of Parkinson's Disease Treatment by HiPSCs Derived Dopaminergic Neural Precursor Cells Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06673615 on ClinicalTrials.gov ↗ ← All trials in China